About Telomir Pharmaceuticals
Telomir Pharmaceuticals is a private company based in Tampa, Florida, incorporated in 2021 in Florida. It has reported $1,000,000 raised in one offering on Form D since April 2023. Its chief executive is Chris Chapman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 15, 2023 | Apr 3, 2023 | $1,000,000fully sold | 10 | $100K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Telomir Pharmaceuticals's Form D filed Apr 3, 2023.
TT
Tuck Talhia
Director
CE
DV
David Vorhoff
Director
JM
James McNulty
Treasurer, Chief Financial Officer and Secretary
CC
Chris Chapman
President, Chief Executive Officer and Chairman
HM
Hugh McColl
Director
JU
Jude Uzonwanne
Director